Long-Acting, Subcutaneous Levodopa In Parkinson's Disease: Is It Safe? Long-Acting, Subcutaneous Levodopa In Parkinson's Disease: Is It Safe?
Priming the pump in Parkinson ' s disease -- a new levodopa solution. Join Dr Andrew Wilner as he discusses the safety of this new method of administration with Dr Jason Aldred.Medscape Neurology (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - September 7, 2022 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news
Some 'Dopamine Bean' Supplements Show High Levels of Parkinson's Drug
(MedPage Today) -- A type of supplement known as the "dopamine bean" can contain very high levels of levodopa -- in some cases, higher than prescription formulations used to treat Parkinson's disease, researchers found.
Among 15 brands of Mucuna... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 8, 2022 Category: American Health Source Type: news
Study: Dangerous levels of levodopa found in certain botanical supplements
A new study found botanical supplements of mucuna pruriens, a tropical legume, contained high levels of levodopa that could harm health -- and " unpredictably complicate " management of Parkinson's disease. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 8, 2022 Category: Consumer Health News Source Type: news
Dhivy (Carbidopa and Levodopa Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 13, 2022 Category: Drugs & Pharmacology Source Type: news
AbbVie Submits New Drug Application to U.S. FDA for Investigational ABBV-951 (Foscarbidopa/Foslevodopa) for the Treatment of Advanced Parkinson's Disease
If approved, ABBV-951 will offer patients the first continuous subcutaneous delivery of carbidopa/levodopa prodrugs
Submission is supported by Phase 3 study that demonstrated patients had significant increases in hours of " On " time without... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - May 20, 2022 Category: Drugs & Pharmacology Source Type: news
Avion Pharmaceuticals, LLC, an Alora Pharmaceuticals company, announces the FDA approval and availability of DHIVY(TM) for the treatment of Parkinson's disease
Parkinson's Disease Treatment is the First and Only Carbidopa/Levodopa (CD/LD) TabletDesigned to be Divided for Precise Dosing
ALPHARETTA, Ga., Feb. 14, 2022 -- (Healthcare Sales & Marketing Network) -- Avion Pharmaceuticals, LLC, an Alora Pharmaceutic... Biopharmaceuticals, Neurology, FDA Avion Pharmaceuticals, Alora Pharmaceuticals, Parkinson's Disease, DHIVY (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 14, 2022 Category: Pharmaceuticals Source Type: news
Dopamine Agonists, DRIs Similar for QoL in Parkinson Disease
WEDNESDAY, Dec. 29, 2021 -- For patients with Parkinson disease on levodopa therapy, patient-rated quality of life is similar for those receiving adjuvant therapy with dopamine agonists compared with dopamine reuptake inhibitors (DRIs), and among... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 29, 2021 Category: Pharmaceuticals Source Type: news
New Insight Into Best Meds for Parkinson's Motor Fluctuations New Insight Into Best Meds for Parkinson's Motor Fluctuations
Although dopamine agonists and dopamine reuptake inhibitors (DRIs) may be effective in treating Parkinson ' s disease and motor fluctuations not controlled with levodopa, not all DRIs are equal.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - December 29, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Inbrija (Levodopa Inhalation Powder) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 11, 2021 Category: Drugs & Pharmacology Source Type: news
Positive Topline Results of Novel Drug for PD Motor Fluctuations Positive Topline Results of Novel Drug for PD Motor Fluctuations
Topline results from the phase 3 RISE-PD trial show that a novel extended-release form of carbidopa/levodopa provides superior"good on" time for motor fluctuations in Parkinson ' s disease.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - August 26, 2021 Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news
Levodopa cost effective versus levodopa-sparing therapy in early PD
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - May 1, 2021 Category: Drugs & Pharmacology Source Type: news
Adamas Announces FDA Approval for Second Indication for Gocovri as an Adjunctive Treatment to levodopa/carbidopa in Parkinson ’s Disease Patients Experiencing OFF Episodes
EMERYVILLE, Calif.--(BUSINESS WIRE)--Feb. 1, 2021-- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 1, 2021 Category: Drugs & Pharmacology Source Type: news
Long Duration Levodopa Response in Parkinson's Disease Long Duration Levodopa Response in Parkinson's Disease
A new study provides further insights into the duration of response to levodopa in Parkinson ' s disease patients, which may help to clarify treatment strategy over time.Brain (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 1, 2020 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
Prodrugs Infusion Beats Oral PD Therapy for Motor Symptoms Prodrugs Infusion Beats Oral PD Therapy for Motor Symptoms
A continuous subcutaneous infusion of foslevodopa/foscarbidopa controlled the motor symptoms of advanced Parkinson ' s disease better compared with oral levodopa/carbidopa, a study shows.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 12, 2020 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Parkinson's Drug Levodopa Eyed as Treatment for Severe Macular Degeneration
WEDNESDAY, Sept. 16, 2020 -- A drug long used to treat Parkinson ' s disease may benefit patients with a severe form of age-related macular degeneration (AMD), a small clinical trial suggests.
One of the leading causes of vision loss in older people... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 16, 2020 Category: General Medicine Source Type: news
